Full-Year 2025 revenue of
Company Continues to Drive Meaningful Cost Reductions
Company Issues Full Year 2026 Financial Guidance
Strategic Alternatives Review Advancing with Clear Path Forward Expected in Q2
The consolidated results incorporate the financial position and performance of
Fourth Quarter 2025 Results:
- Revenue:
$35.3 million , a 142.4% increase from$14.6 million year-over-year - Gross Margin (“GM”): 37.7%, up from 32.9% year-over-year
- Adjusted Gross Margin (“Adjusted GM”): 49.7%, up from 36.3% year-over-year
- Adjusted EBITDA loss:
$9.8 million , down from a loss of$18.9 million year-over-year - Net Loss from Continuing Operations:
$33.9 million , up from a loss of$9.3 million year-over-year - Total cash, cash equivalents, deposits and marketable equity securities:
$459.6 million as ofDecember 31, 2025 , down from$515.5 million as ofSeptember 30, 2025 . This change of approximately$55.9 million includes$19.8 million of cash used for share repurchases during the quarter and$24.4 million related to changes in the fair value of marketable equity securities.
Full Year 2025 Results:
- Revenue:
$102.4 million , a 77.3% increase from$57.8 million year-over-year GM : 33.5%, down from 43.1% year-over-year- Adjusted
GM : 46.9%, up from 45.4% year-over-year - Adjusted EBITDA loss:
$53.2 million , down from a loss of$63.6 million year-over-year - Net Loss from Continuing Operations:
$100.4 million , up from a loss of$99.9 million year-over-year
More information, including a reconciliation of Adjusted EBITDA and Adjusted Gross Margin to the most directly comparable GAAP financial measure can be found below in this press release under “Non-GAAP Financial Measures” and “Reconciliation of US GAAP to Non-GAAP Measures.”
Recent Developments
- Operating Discipline and Cost Savings: During 2025, the Company made meaningful progress driving cost savings by streamlining operations and focusing resources on priority industry segments and products. Non-GAAP operating expenses* declined sequentially in the fourth quarter to
$27.3 million , representing a reduction of more than 16% relative to the previously identified baseline of approximately$32.5 million , which reflects second quarter 2025 operating expenses adjusted to include a full quarter ofMarkforged . This reduction highlights the substantial execution of the Company’s previously announced cost reduction initiatives, with the full benefits expected to be realized in early 2026. The Company continues to evaluate additional opportunities to enhance operational performance and believes these initiatives position it to drive improved operating leverage over time. - Re-domestication and
U.S. Reporting Transition: EffectiveJanuary 1, 2026 ,Nano Dimension began reporting as aU.S. domestic issuer. The Company filed its Form 10-K today and anticipates completing the re-domestication process in the first half of 2026, subject to customary approvals. This transition aligns the Company’s reporting and governance framework with U.S. market standards while enhancing transparency for shareholders. - Share Repurchases and Capital Allocation: During 2025, the Company remained disciplined in capital allocation while preserving balance sheet strength and strategic flexibility. In the fourth quarter, the Company repurchased approximately 10.9 million shares for approximately
$19.2 million under its existing$150 million authorization. Given the ongoing strategic alternatives review process, the Board is carefully evaluating capital deployment priorities and will not be providing forward-looking updates regarding repurchase activity at this time. - Strategic Alternatives Review: The Board, with the support of
Guggenheim Securities, LLC and Houlihan Lokey, has conducted a thorough and disciplined review of strategic alternatives, evaluating product lines, core technologies, market dynamics and competitive positioning. The Company has made meaningful progress, including reducing losses and improving its product portfolio, while recognizing that a gap remains to achieving sustained profitability.Nano Dimension expects to announce a series of actions in the second quarter of 2026 to clearly define its path forward to maximizing shareholder value.
* More information, including a reconciliation of non-GAAP operating expenses to the most directly comparable GAAP financial measure can be found below in this press release under “Non-GAAP Financial Measures” and “Reconciliation of US GAAP to Non-GAAP Measures.”
2026 Financial Guidance
Following improved visibility exiting 2025 and continued integration of
For the full year 2026, the Company anticipates revenue in the range of
Non-GAAP gross margin, non-GAAP operating expenses and Adjusted EBITDA represent non-GAAP financial measures. Additional information can be found below in this press release under “Non-GAAP Financial Measures.”
Conference Call Today
Participants can pre-register for the conference call in order to receive dial in information via this link: https://dpregister.com/sreg/10206850/10359dca11a
Participants can also dial-in/connect by following the below:
Listen in via
Listen via international dial-in: 1-412-902-6751
Listen via
Listen via webcast: https://event.choruscall.com/mediaframe/webcast.html?webcastid=1YPvoqSL
For those unable to participate in the conference call, there will be a replay available from a link on Nano Dimension’s website at https://investors.nano-di.com/events-and-presentations.
About
Driven by strong trends in onshoring, national security, and increasing product customization,
Non-GAAP Financial Measures
EBITDA is a non-GAAP measure and is defined as earnings before interest income and expense, income tax (benefit) expense, depreciation and amortization. We believe that EBITDA should be useful in evaluating the performance of our business and operations. EBITDA facilitates operating performance comparisons from period to period and company to company by backing out potential differences caused by variations in capital structures (affecting interest expenses (income), net), and the age and depreciation charges and amortization of fixed and intangible assets, respectively (affecting relative depreciation and amortization expense, respectively) and EBITDA is useful to an investor in evaluating our operating performance because it is widely used by investors, securities analysts and other interested parties to measure a company’s operating performance without regard to the items mentioned above.
Adjusted EBITDA and operating expenses are non-GAAP measures and are defined as earnings before interest income and expense, income tax (benefit) expense, depreciation and amortization, share-based compensation expense, exchange rate differences, finance expenses (income) for revaluation of assets and liabilities, Desktop Metal litigation related expenses, Desktop Metal and
Adjusted gross profit, excluding depreciation and amortization, share-based compensation expenses, and step-up amortization from purchase accounting, is a non-GAAP measure. We believe that adjusted gross profit, as described above, should also be useful in evaluating the performance of our business. Adjusted gross profit facilitates gross profit and gross margin comparisons from period to period and company to company by backing out potential differences caused by variations in amortization of inventory and intangible assets. Adjusted gross profit is useful to an investor in evaluating our performance because it enables investors, securities analysts and other interested parties to measure a company’s performance without regard to non-cash items, such as amortization expenses. Adjusted gross margin is calculated by dividing the adjusted gross profit by the revenues.
EBITDA and Adjusted EBITDA, Adjusted gross profit and non-GAAP operating expenses can be useful in evaluating our performance by eliminating the effect of financing and non-cash expenses such as share-based payments, however, we may incur such expenses in the future, which could impact future results. In addition, other companies, including companies in our industry, may calculate non-GAAP metrics differently or not at all, which may reduce the usefulness of this measure as a tool for comparison.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include statements regarding Nano’s future growth, strategic plan and value to shareholders, and all other statements other than statements of historical fact that address activities, events or developments that Nano intends, expects, projects, believes or anticipates will or may occur in the future. Forward-looking statements may be characterized by terminology such as “believe,” “project,” “expect,” “anticipate,” “estimate,” “forecast,” “outlook,” “target,” “endeavor,” “seek,” “predict,” “intend,” “strategy,” “plan,” “may,” “could,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” or the negative thereof or variations thereon or similar terminology generally intended to identify forward-looking statements. Such statements are based on management’s beliefs and assumptions made based on information currently available to management. These forward-looking statements involve known and unknown risks and uncertainties, which may cause the Company’s actual results and performance to be materially different from those expressed or implied in the forward-looking statements. Accordingly, we caution you that any such forward-looking statements are not guarantees of future performance and are subject to risks, assumptions, estimates and uncertainties that are difficult to predict. Because such statements deal with future events and are based on the current expectations of Nano, they are subject to various risks and uncertainties. The forward-looking statements contained or implied in this communication are subject to other risks and uncertainties, including those discussed under the heading “Risk Factors” in Nano’s annual report on Form 20-F filed with the Securities and Exchange Commission (the “SEC”) on
Contacts:
Investors:
Director, Investor Relations
ir@nano-di.com
Media:
Principal Manager,
press@nano-di.com
CONSOLIDATED BALANCE SHEETS (In thousands, except share data) (audited) | ||||||||
| 2025 | 2024 | |||||||
| Assets | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | $ | 204,672 | $ | 317,169 | ||||
| Bank deposits | 168,997 | 440,790 | ||||||
| Marketable equity securities | 84,154 | — | ||||||
| Restricted bank deposits | 123 | 537 | ||||||
| Trade receivables, net of allowance for doubtful accounts ( | 26,047 | 9,141 | ||||||
| Inventory | 32,878 | 16,899 | ||||||
| Other current assets | 8,938 | 4,790 | ||||||
| Total current assets | 525,809 | 789,326 | ||||||
| Restricted bank deposits | 1,610 | 768 | ||||||
| Marketable equity securities | — | 86,190 | ||||||
| Property, plant and equipment, net | 24,840 | 14,143 | ||||||
| Operating lease right-of-use assets | 23,789 | 9,958 | ||||||
| Deferred tax assets | 424 | — | ||||||
| 40,388 | — | |||||||
| Intangible assets, net | 19,434 | 2,155 | ||||||
| Other assets | 1,930 | — | ||||||
| Total assets | $ | 638,224 | $ | 902,540 | ||||
| Liabilities and Equity | ||||||||
| Current liabilities: | ||||||||
| Trade payables | $ | 11,999 | $ | 4,249 | ||||
| Accrued liabilities | 19,514 | 18,771 | ||||||
| Deferred revenue | 11,873 | 3,523 | ||||||
| Current portion of lease liability | 8,923 | 3,421 | ||||||
| Current portion of bank loan | 158 | 138 | ||||||
| Total current liabilities | 52,467 | 30,102 | ||||||
| Employee benefits | 3,697 | 4,700 | ||||||
| Operating lease right-of-use liabilities | 23,323 | 6,707 | ||||||
| Bank loan | 158 | 276 | ||||||
| Long-term settlement payable | 2,974 | — | ||||||
| Long-term deferred revenue | 3,617 | — | ||||||
| Total liabilities | 86,236 | 41,785 | ||||||
| Commitments and contingencies | ||||||||
| Non-controlling interests | — | 715 | ||||||
| Equity: | ||||||||
| Share capital of | 417,084 | 409,145 | ||||||
| Additional paid-in capital | 1,297,323 | 1,297,348 | ||||||
| (192,507 | ) | (167,651 | ) | |||||
| Accumulated other comprehensive income (loss) | 1,048 | (1,137 | ) | |||||
| Accumulated loss | (970,960 | ) | (677,665 | ) | ||||
| Total equity attributable to common shareholders | 551,988 | 860,040 | ||||||
| Total equity | 551,988 | 860,755 | ||||||
| Total liabilities and equity | $ | 638,224 | $ | 902,540 | ||||
CONSOLIDATED STATEMENTS OF OPERATIONS (In thousands, except per share data) (audited) | ||||||||||||
| For the Year Ended | ||||||||||||
| 2025(1) | 2024 | 2023 | ||||||||||
| Revenue: | ||||||||||||
| Product | $ | 80,385 | $ | 45,557 | $ | 47,231 | ||||||
| Service | 22,052 | 12,218 | 9,083 | |||||||||
| Total revenue | 102,437 | 57,775 | 56,314 | |||||||||
| Cost of revenue: | ||||||||||||
| Product | 57,923 | 26,308 | 23,358 | |||||||||
| Service | 10,169 | 6,578 | 6,898 | |||||||||
| Total cost of revenue | 68,092 | 32,886 | 30,256 | |||||||||
| Gross profit | 34,345 | 24,889 | 26,058 | |||||||||
| Operating expenses: | ||||||||||||
| Research and development | 30,054 | 39,558 | 65,146 | |||||||||
| Sales and marketing | 35,713 | 27,657 | 34,258 | |||||||||
| General and administrative | 59,766 | 45,987 | 55,973 | |||||||||
| Restructuring | 7,581 | — | — | |||||||||
| Desktop Metal litigation | 31,046 | — | — | |||||||||
| Impairment losses | 10,516 | 1,283 | — | |||||||||
| Operating loss | (140,331 | ) | (89,596 | ) | (129,319 | ) | ||||||
| (Loss) gain on investment in marketable equity securities | (2,036 | ) | (52,256 | ) | 23,462 | |||||||
| Other (expense) income, net | (479 | ) | 486 | 1,627 | ||||||||
| Finance income | 35,400 | 42,573 | 47,584 | |||||||||
| Finance expense | (111 | ) | (668 | ) | (367 | ) | ||||||
| Loss before income taxes | (107,557 | ) | (99,461 | ) | (57,013 | ) | ||||||
| Income tax benefit (expense) | 7,202 | (397 | ) | (62 | ) | |||||||
| Net loss from continuing operations | (100,355 | ) | (99,858 | ) | (57,075 | ) | ||||||
| Net loss from discontinued operations, net of income tax of nil | (193,263 | ) | — | — | ||||||||
| Net loss | (293,618 | ) | (99,858 | ) | (57,075 | ) | ||||||
| Less: Net loss attributable to non-controlling interests | (323 | ) | (1,029 | ) | (1,110 | ) | ||||||
| Net loss attributable to common shareholders | $ | (293,295 | ) | $ | (98,829 | ) | $ | (55,965 | ) | |||
| Net loss attributable to common shareholders: | ||||||||||||
| Continuing operations - basic and diluted | $ | (0.46 | ) | $ | (0.45 | ) | $ | (0.23 | ) | |||
| Discontinued operations - basic and diluted | $ | (0.90 | ) | $ | — | $ | — | |||||
| Weighted average common shares outstanding, basic and diluted | 215,742 | 218,311 | 248,019 | |||||||||
| Net loss | $ | (293,618 | ) | $ | (99,858 | ) | $ | (57,075 | ) | |||
| Other comprehensive income (loss): | ||||||||||||
| Foreign currency translation adjustment | 1,791 | (1,944 | ) | 2,368 | ||||||||
| Remeasurement of pension and post-employment benefit plans, net of tax | 312 | (2,769 | ) | (1,920 | ) | |||||||
| Comprehensive loss | (291,515 | ) | (104,571 | ) | (56,627 | ) | ||||||
| Less: Comprehensive loss attributable to non-controlling interests | (323 | ) | (1,088 | ) | (1,088 | ) | ||||||
| Comprehensive loss attributable to common shareholders | $ | (291,192 | ) | $ | (103,483 | ) | $ | (55,539 | ) | |||
(1) The results for the year ended
CONSOLIDATED STATEMENTS OF CASH FLOWS (In thousands) (audited) | ||||||||||||
| For the Year Ended | ||||||||||||
| 2025 | 2024 | 2023 | ||||||||||
| Cash flow from operating activities | ||||||||||||
| Net loss from continuing operations | $ | (100,355 | ) | $ | (99,858 | ) | $ | (57,075 | ) | |||
| Adjustments: | ||||||||||||
| Depreciation, amortization and non-cash lease interest | 20,455 | 2,642 | 1,972 | |||||||||
| Impairment losses | 10,516 | 1,350 | 326 | |||||||||
| Changes in fair value of equity securities | 2,037 | 52,256 | (23,462 | ) | ||||||||
| Loss from deconsolidation of subsidiaries | 1,666 | — | — | |||||||||
| Share-based compensation expense | 4,930 | 15,721 | 22,110 | |||||||||
| Changes in assets and liabilities: | ||||||||||||
| Decrease (increase) in inventory | 5,596 | 387 | (340 | ) | ||||||||
| (Increase) decrease in other current assets | (175 | ) | 6,078 | (5,775 | ) | |||||||
| (Increase) decrease in trade receivables | (1,535 | ) | 2,950 | (5,603 | ) | |||||||
| Increase in deferred tax assets | (7,456 | ) | — | (11 | ) | |||||||
| (Decrease) increase in other payables | (9,993 | ) | (1,150 | ) | 4,856 | |||||||
| (Decrease) increase in employee benefits | (1,393 | ) | (562 | ) | (1,478 | ) | ||||||
| Increase in trade payables | 6,866 | 47 | 1,089 | |||||||||
| Other | (1,426 | ) | 1,218 | (5,266 | ) | |||||||
| Net cash used in operating activities | (70,267 | ) | (18,921 | ) | (68,657 | ) | ||||||
| Cash flow relating to investing activities | ||||||||||||
| Change in bank deposits | 270,755 | 100,530 | (189,060 | ) | ||||||||
| Purchase of property plant and equipment | (1,064 | ) | (2,196 | ) | (9,098 | ) | ||||||
| Acquisition of intangible asset | — | (711 | ) | (1,524 | ) | |||||||
| Acquisition of subsidiaries, net of cash acquired | (267,816 | ) | — | — | ||||||||
| Deconsolidation of subsidiaries | (476 | ) | — | — | ||||||||
| Other | — | — | 835 | |||||||||
| Net cash from (used in) investing activities | 1,399 | 97,623 | (198,847 | ) | ||||||||
| Cash flow relating to financing activities | ||||||||||||
| Repayment long-term bank debt | (149 | ) | (180 | ) | (536 | ) | ||||||
| Proceeds from non-controlling interests | — | 555 | 1,089 | |||||||||
| Payment of a liability for contingent consideration in a business combination | — | — | (9,255 | ) | ||||||||
| Payments of share price protection recognized in business combination | — | (363 | ) | (4,459 | ) | |||||||
| Repurchase of treasury shares | (24,856 | ) | (69,755 | ) | (96,387 | ) | ||||||
| Net cash used in financing activities | (25,005 | ) | (69,743 | ) | (109,548 | ) | ||||||
| Cash flow relating to discontinued operations | ||||||||||||
| Net cash used in operating activities | (31,017 | ) | — | — | ||||||||
| Net cash used in investing activities | (437 | ) | — | — | ||||||||
| Net cash provided by financing activities | 10,009 | — | — | |||||||||
| Net cash used in discontinued operations | (21,445 | ) | — | — | ||||||||
| (Decrease) increase in cash, cash equivalents and restricted cash | (115,318 | ) | 8,959 | (377,052 | ) | |||||||
| Effect of exchange rate fluctuations on cash | 3,249 | (997 | ) | 1,292 | ||||||||
| Cash, cash equivalents and restricted cash at beginning of the year | 318,474 | 310,512 | 686,272 | |||||||||
| Cash, cash equivalents and restricted cash at end of the year | $ | 206,405 | $ | 318,474 | $ | 310,512 | ||||||
| Supplemental disclosures of cash flow information | ||||||||||||
| Cash and cash equivalents | $ | 204,672 | 317,169 | 309,571 | ||||||||
| Restricted cash in restricted deposits, current | 123 | 537 | 60 | |||||||||
| Restricted cash in restricted deposits, non-current | 1,610 | 768 | 881 | |||||||||
| Total cash, cash equivalents and restricted cash shown in the consolidated statements of cash flows | $ | 206,405 | $ | 318,474 | $ | 310,512 | ||||||
| Non-cash operating activity | ||||||||||||
| Intangible asset acquired on credit | — | — | 711 | |||||||||
| Property plant and equipment acquired on credit | 17 | 69 | 214 | |||||||||
| Lease liabilities arising from obtaining right-of-use assets | 1,167 | 1,275 | 929 | |||||||||
| Non-cash investing activity | ||||||||||||
| Acquisition replacement awards for pre-combination service | 2,055 | — | — | |||||||||
| Supplemental disclosure of cash flow information | ||||||||||||
| Income taxes paid during the year | 115 | 314 | 136 | |||||||||
| RECONCILIATION OF US GAAP TO NON-GAAP MEASURES | ||||||||||||||||
| (In thousands) | ||||||||||||||||
| ? | Three Months Ended | ? | Year Ended | |||||||||||||
| ? | 2025 | 2024 | ? | 2025 | 2024 | |||||||||||
| GAAP Net loss from continuing operations | ? | $ | (33,942 | ) | $ | (9,333 | ) | ? | $ | (100,355 | ) | $ | (99,858 | ) | ||
| Tax expense (benefit) | ? | (7,325 | ) | 319 | ? | (7,202 | ) | 397 | ||||||||
| Depreciation and amortization | 2,407 | 772 | 7,433 | 2,642 | ||||||||||||
| Interest expense | 543 | — | 971 | — | ||||||||||||
| Interest income | (4,503 | ) | (10,092 | ) | (24,636 | ) | (42,573 | ) | ||||||||
| Non-GAAP EBITDA (loss) | (42,820 | ) | (18,334 | ) | (123,789 | ) | (139,392 | ) | ||||||||
| Finance expenses (income) from revaluation of assets and liabilities | 24,431 | (5,583 | ) | 2,056 | 52,344 | |||||||||||
| Exchange rate differences | (2,264 | ) | (2,150 | ) | (10,764 | ) | 485 | |||||||||
| Share-based payments expense | 1,912 | 3,213 | 4,930 | 15,721 | ||||||||||||
| Desktop Metal litigation related expenses | 138 | — | 31,046 | — | ||||||||||||
| Desktop Metal and | 106 | 3,010 | 10,614 | 6,452 | ||||||||||||
| Restructuring costs | 532 | — | 7,581 | — | ||||||||||||
| Impairment losses | 2,110 | 1,283 | 10,516 | 1,283 | ||||||||||||
| Acquisition inventory step-up amortization | 3,209 | — | 10,661 | — | ||||||||||||
| Litigation settlements and contingencies | 3,521 | — | 4,621 | — | ||||||||||||
| Other non-GAAP | (711 | ) | (371 | ) | (711 | ) | (486 | ) | ||||||||
| Non-GAAP Adjusted EBITDA from continuing operations | ? | $ | (9,836 | ) | $ | (18,932 | ) | ? | $ | (53,239 | ) | $ | (63,593 | ) | ||
| ? | Three Months Ended | ? | Year Ended | |||||||||||||
| Non-GAAP Cost of Revenue | ? | 2025 | 2024 | ? | 2025 | 2024 | ||||||||||
| GAAP Cost of revenue | ? | $ | 21,998 | $ | 9,775 | ? | $ | 68,092 | $ | 32,886 | ||||||
| Share-based payments expense | ? | 172 | 228 | ? | 669 | 938 | ||||||||||
| Depreciation and amortization | 856 | 266 | ? | 2,400 | 374 | |||||||||||
| Acquisition inventory step-up amortization | 3,209 | — | 10,661 | — | ||||||||||||
| Non-GAAP Cost of revenue | $ | 17,761 | $ | 9,281 | $ | 54,362 | $ | 31,574 | ||||||||
| ? | Three Months Ended | ? | Year Ended | |||||||||||||
| Non-GAAP Gross Profit | ? | 2025 | 2024 | ? | 2025 | 2024 | ||||||||||
| GAAP Gross profit | ? | $ | 13,317 | $ | 4,794 | ? | $ | 34,345 | $ | 24,889 | ||||||
| Share-based payments expense | ? | 172 | 228 | ? | 669 | 938 | ||||||||||
| Depreciation and amortization | 856 | 266 | ? | 2,400 | 374 | |||||||||||
| Acquisition inventory step-up amortization | 3,209 | — | 10,661 | — | ||||||||||||
| Non-GAAP Gross profit | $ | 17,554 | $ | 5,288 | $ | 48,075 | $ | 26,201 | ||||||||
| ? | Three Months Ended | ? | Year Ended | |||||||||||||
| ? | 2025 | 2024 | ? | 2025 | 2024 | |||||||||||
| ? | $ | 7,466 | $ | 9,449 | ? | $ | 30,054 | $ | 39,558 | |||||||
| Share-based payments expense | ? | 454 | 1,215 | ? | 1,708 | 6,079 | ||||||||||
| Depreciation and amortization | 424 | 493 | ? | 1,432 | 1,355 | |||||||||||
| $ | 6,588 | $ | 7,741 | $ | 26,914 | $ | 32,124 | |||||||||
| ? | Three Months Ended | ? | Year Ended | |||||||||||||
| Non-GAAP Sales and Marketing Expenses | ? | 2025 | 2024 | ? | 2025 | 2024 | ||||||||||
| GAAP Sales and marketing expenses | ? | $ | 10,065 | $ | 6,504 | ? | $ | 35,713 | $ | 27,657 | ||||||
| Share-based payments expense | ? | 208 | 274 | ? | 896 | 1,649 | ||||||||||
| Depreciation and amortization | 769 | 143 | ? | 2,221 | 518 | |||||||||||
| Non-GAAP Sales and marketing expenses | $ | 9,088 | $ | 6,087 | $ | 32,596 | $ | 25,490 | ||||||||
| ? | Three Months Ended | ? | Year Ended | |||||||||||||
| Non-GAAP General and Administrative Expenses | ? | 2025 | 2024 | ? | 2025 | 2024 | ||||||||||
| GAAP General and administrative expenses | ? | $ | 16,681 | $ | 14,743 | ? | $ | 59,766 | $ | 45,987 | ||||||
| Share-based payments expense | ? | 1,078 | 1,496 | ? | 1,657 | 7,055 | ||||||||||
| Depreciation and amortization | 358 | (130 | ) | ? | 1,380 | 395 | ||||||||||
| Desktop Metal and | 106 | 3,010 | 10,614 | 6,452 | ||||||||||||
| Other non-GAAP | — | — | — | (115 | ) | |||||||||||
| Litigation settlements and contingencies | 3,521 | — | 4,621 | — | ||||||||||||
| Non-GAAP General and administrative expenses | $ | 11,618 | $ | 10,367 | $ | 41,494 | $ | 32,200 | ||||||||
| ? | Three Months Ended | ? | Year Ended | |||||||||||||
| Non-GAAP Operating Loss | ? | 2025 | 2024 | ? | 2025 | 2024 | ||||||||||
| GAAP Operating loss | ? | $ | (23,675 | ) | $ | (27,185 | ) | ? | $ | (140,331 | ) | $ | (89,596 | ) | ||
| Share-based payments expense | ? | 1,912 | 3,213 | ? | 4,930 | 15,721 | ||||||||||
| Depreciation and amortization | 2,407 | 772 | ? | 7,433 | 2,642 | |||||||||||
| Desktop Metal litigation related expenses | 138 | — | 31,046 | — | ||||||||||||
| Desktop Metal and | 106 | 3,010 | 10,614 | 6,452 | ||||||||||||
| Restructuring costs | 532 | — | 7,581 | — | ||||||||||||
| Impairment losses | 2,110 | 1,283 | 10,516 | 1,283 | ||||||||||||
| Acquisition inventory step-up amortization | 3,209 | — | 10,661 | — | ||||||||||||
| Litigation settlements and contingencies | 3,521 | — | 4,621 | — | ||||||||||||
| Other non-GAAP | — | — | — | (115 | ) | |||||||||||
| Non-GAAP Operating loss | $ | (9,740 | ) | $ | (18,907 | ) | $ | (52,929 | ) | $ | (63,613 | ) | ||||
Source: 